Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Nurix Therapeutics, Inc. | Director | Director Stock Option (right to buy) | 17.5K | May 6, 2021 | Direct | ||
LogicBio Therapeutics, Inc. | Director | Common Stock | 0 | $2.01 | Nov 16, 2022 | Direct | |
LogicBio Therapeutics, Inc. | Director | Stock Option (right to buy) | 0 | Nov 16, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
LOGC | LogicBio Therapeutics, Inc. | Nov 16, 2022 | 3 | $0 | 4 | Nov 17, 2022 | Director |
LOGC | LogicBio Therapeutics, Inc. | Jun 17, 2022 | 1 | $0 | 4 | Jun 21, 2022 | Director |
LOGC | LogicBio Therapeutics, Inc. | Jun 11, 2021 | 1 | $0 | 4 | Jun 14, 2021 | Director |
NRIX | Nurix Therapeutics, Inc. | May 6, 2021 | 1 | $0 | 4 | May 24, 2021 | Director |